Pardo Joe, Klinker Kenneth P, Swift Barbara, Borgert Samuel J, Gravenstein Nikolaus
Clinical Specialist, Infectious Diseases, Department of Pharmacy, North Florida/South Georgia Veterans Health System, Gainesville, Florida.
Clinical Specialist, Infectious Diseases, Department of Pharmacy, University of Florida Health Shands Hospital, Gainesville, Florida.
Hosp Pharm. 2016 Jan;51(1):44-48. doi: 10.1310/hpj5101-44. Epub 2018 Sep 14.
A local quality initiative to improve compliance with surgical antibiotic prophylaxis measures resulted in a high percentage of patients receiving antibiotics within minutes of surgical incision. Studies examining the association between timing of prophylaxis and the risk for surgical site infection (SSI) have produced heterogeneous results.
To examine risk factors for SSI, including "just in time" dosing of antibiotic prophylaxis (dose administered within 5 minutes of incision).
This was a retrospective matched case-control study. Case patients developed SSI in the 30 days following a clean or clean-contaminated surgical procedure. Control patients did not develop SSI following similar procedures and were matched to ensure comparable baseline risk. We assessed the rate of guideline-compliant antibiotic prophylaxis and calculated odds ratios (ORs) to determine the association of patient covariates with the risk for SSI.
Forty case patients and 104 controls were included in the study. The rate of appropriate prophylaxis was high in both groups (98% and 94% for case and control groups, respectively). Approximately 15% of case and control patients received antibiotic prophylaxis within 5 minutes of incision, thus, "just in time" dosing did not appear to increase the risk for SSI (OR, 0.814; 95% CI, 0.274-2.415). There was a nonsignificant association between receipt of vancomycin and SSI (OR, 2.844; 95% CI, 0.926-8.737).
"Just in time" dosing of prophylactic antibiotics was not associated with increased risk for SSI. Further study is needed to clarify the impact of antibiotic choice on the risk for subsequent SSI.
一项旨在提高手术抗生素预防措施依从性的地方质量改进举措,使得很大比例的患者在手术切口几分钟内就接受了抗生素治疗。研究预防性用药时机与手术部位感染(SSI)风险之间的关联,结果并不一致。
探讨SSI的风险因素,包括抗生素预防性用药的“及时”给药(在切口后5分钟内给药)。
这是一项回顾性配对病例对照研究。病例组患者在清洁或清洁-污染手术后30天内发生了SSI。对照组患者在类似手术后未发生SSI,并进行配对以确保基线风险相当。我们评估了符合指南的抗生素预防性用药率,并计算优势比(OR)以确定患者协变量与SSI风险之间的关联。
该研究纳入了40例病例患者和104例对照患者。两组的适当预防性用药率都很高(病例组和对照组分别为98%和94%)。大约15%的病例组和对照组患者在切口后5分钟内接受了抗生素预防性用药,因此,“及时”给药似乎并未增加SSI风险(OR,0.814;95%CI,0.274-2.415)。接受万古霉素治疗与SSI之间存在无统计学意义的关联(OR,2.844;95%CI,0.926-8.737)。
预防性抗生素的“及时”给药与SSI风险增加无关。需要进一步研究以阐明抗生素选择对后续SSI风险的影响。